Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species

Diagnostic Microbiology and Infectious Disease

Volumn 80, Issue 3, 2014, Pages 227-232

  Papadimitriou Olivgeris, Matthaios ^a   Spiliopoulou, Anastasia ^a   Fligou, Fotini ^a   Manolopoulou, Patroula ^b   Spiliopoulou, Iris ^a   Vrettos, Theofanis ^a   Dodou, Vasiliki ^b   Filos, Kriton S ^a   Anastassiou, Evangelos D ^a   Marangos, Markos ^a   Christofidou, Myrto ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

Author keywords

Candidemia; Critically ill patients; Intensive care unit

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CARBAPENEM DERIVATIVE; CASPOFUNGIN; CEPHALOSPORIN DERIVATIVE; COLISTIN; CORTISONE; FLUCONAZOLE; ITRACONAZOLE; LINEZOLID; METRONIDAZOLE; MICAFUNGIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; VORICONAZOLE; ANTIFUNGAL AGENT; BETA LACTAMASE;

ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIAL COLONIZATION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDEMIA; COLOSTOMY; CONTROLLED STUDY; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; GENDER; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; KLUYVEROMYCES MARXIANUS; KPC PRODUCING KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OBESITY; PARENTERAL NUTRITION; PICHIA KUDRIAVZEVII; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SUMMER; TRANSPLANTATION; AGED; CANDIDIASIS; CLASSIFICATION; COMPLICATION; CRITICAL ILLNESS; ENZYMOLOGY; HETEROZYGOTE; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIOLOGY; SECRETION (PROCESS); TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BETA-LACTAMASES; CANDIDA; CANDIDIASIS; CARRIER STATE; CRITICAL ILLNESS; FEMALE; FLUCONAZOLE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84927520603     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.07.012     Document Type: Article

References (35)

1. Agvald-Ohman C., Klingspor L., Hjelmqvist H., Edlund C. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2008, 40:145-153.
2. Almirante B., Rodriguez D., Cuenca-Estrella M., Almela M., Sanchez F., Ayats J., et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006, 44:1681-1685.
3. Asmundsdottir L.R., Erlendsdottir H., Gottfredsson M. Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol 2013, 51:841-848.
4. Bassetti M., Righi E., Costa A., Fasce R., Molinari M.P., Rosso R., et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006, 6:21.
5. Blumberg H.M., Jarvis W.R., Soucie J.M., Edwards J.E., Patterson J.E., Pfaller M.A., et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001, 33:177-186.
6. Bouza E., Munoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents 2008, 32(Suppl. 2):S87-S91.
7. Chaudhury A., Nath G., Shukla B., Panda S., Singh T.B. Diarrhoea associated with Candida spp.: incidence and seasonal variation. J Diarrhoeal Dis Res 1996, 14:110-112.
8. Chen Y.C., Chang S.C., Tai H.M., Hsueh P.R., Luh K.T. Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc 2001, 100:791-797.
9. Chow J.K., Golan Y., Ruthazer R., Karchmer A.W., Carmeli Y., Lichtenberg D., et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008, 46:1206-1213.
10. Chow J.K., Golan Y., Ruthazer R., Karchmer A.W., Carmeli Y., Lichtenberg D.A., et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 2008, 36:1993-1998.
11. Clinical and Laboratory Standards Institute (CLSI) Principles and procedures for detection of fungi in clinical specimens-direct examination and culture. Approved Guideline-CLSI document M54-A 2012, [Wayne, PA: USA].
12. Collins L.A., Samore M.H., Roberts M.S., Luzzati R., Jenkins R.L., Lewis W.D., et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994, 170:644-652.
13. Cornistein W., Mora A., Orellana N., Capparelli F.J., del Castillo M. Candida: epidemiology and risk factors for non-albicans species. Enferm Infecc Microbiol Clin 2013, 31:380-384.
14. Dimopoulos G., Ntziora F., Rachiotis G., Armaganidis A., Falagas M.E. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 2008, 106:523-529.
15. Dizbay M., Kalkanci A., Sezer B.E., Aktas F., Aydogan S., Fidan I., et al. Molecular investigation of a fungemia outbreak due to Candida parapsilosis in an intensive care unit. Braz J Infect Dis 2008, 12:395-399.
16. Holley A., Dulhunty J., Blot S., Lipman J., Lobo S., Dancer C., et al. Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units. Int J Antimicrob Agents 2009, 33(554):e551-e557.
17. Jorda-Marcos R., Alvarez-Lerma F., Jurado M., Palomar M., Nolla-Salas J., Leon M.A., et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007, 50:302-310.
18. Kaier K., Frank U., Conrad A., Meyer E. Seasonal and ascending trends in the incidence of carriage of extended-spectrum ss-lactamase-producing Escherichia coli and Klebsiella species in 2 German hospitals. Infect Control Hosp Epidemiol 2010, 31:1154-1159.
19. Leroy O., Mira J.P., Montravers P., Gangneux J.P., Lortholary O. Comparison of albicans vs. non-albicans candidemia in French intensive care units. Crit Care 2010, 14:R98.
20. Markogiannakis H., Pachylaki N., Samara E., Kalderi M., Minettou M., Toutouza M., et al. Infections in a surgical intensive care unit of a university hospital in Greece. Int J Infect Dis 2009, 13:145-153.
21. Michalopoulos A.S., Geroulanos S., Mentzelopoulos S.D. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003, 124:2244-2255.
22. Muskett H., Shahin J., Eyres G., Harvey S., Rowan K., Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care 2011, 15:R287.
23. Papadimitriou-Olivgeris M., Marangos M., Fligou F., Christofidou M., Sklavou C., Vamvakopoulou S., et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 2013, 77:169-173.
24. Paphitou N.I., Ostrosky-Zeichner L., Rex J.H. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005, 43:235-243.
25. Pfaller M.A., Diekema D.J. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 2004, 10(Suppl. 1):11-23.
26. Pratikaki M., Platsouka E., Sotiropoulou C., Douka E., Paramythiotou E., Kaltsas P., et al. Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit. Mycoses 2011, 54:154-161.
27. Pultz N.J., Stiefel U., Ghannoum M., Helfand M.S., Donskey C.J. Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice. Antimicrob Agents Chemother 2005, 49:438-440.
28. Samonis G., Kofteridis D.P., Maraki S., Alegakis D., Mantadakis E., Papadakis J.A., et al. Levofloxacin and moxifloxacin increase human gut colonization by Candida species. Antimicrob Agents Chemother 2005, 49:5189.
29. Samra Z., Bishara J., Ashkenazi S., Pitlik S., Weinberger M., Lapidoth M., et al. Changing distribution of Candida species isolated from sterile and nonsterile sites in Israel. Eur J Clin Microbiol Infect Dis 2002, 21:542-545.
30. Spiliopoulou A., Vamvakopoulou S., Bartzavali C., Dimitracopoulos G., Anastassiou E.D., Christofidou M. Eleven-year retrospective survey of candidaemia in a university hospital in southwestern Greece. Clin Microbiol Infect 2010, 16:1378-1381.
31. Spiliopoulou A., Jelastopulu E., Vamvakopoulou S., Bartzavali C., Kolonitsiou F., Anastassiou E.D., et al. In vitro activity of tigecycline and colistin against A. baumannii clinical bloodstream isolates during an 8-year period. J Chemother 2014, [1973947814Y0000000193. [Epub ahead of print]].
32. Tapia G.G., Razonable R.R., Eckel-Passow J.E., Lahr B.D., Afessa B., Keegan M.T., et al. A scoring model of factors associated with Candida glabrata candidemia among critically ill patients. Mycoses 2012, 55:228-236.
33. Vardakas K.Z., Samonis G., Michalopoulos A., Soteriades E.S., Falagas M.E. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006, 34:1216-1224.
34. Wey S.B., Mori M., Pfaller M.A., Woolson R.F., Wenzel R.P. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989, 149:2349-2353.
35. Yang S.P., Chen Y.Y., Hsu H.S., Wang F.D., Chen L.Y., Fung C.P. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study. BMC Infect Dis 2013, 13:10.